First Experience with Osimertinib in Patients with Newly Developed T790M Mutation Previously Treated with EGFR - TKIs in Croatia

被引：0
|
作者：
Jakopovic, M. [1 ]
Bitar, L. [1 ]
Seiwerth, F. [1 ]
Plestina, S. [1 ]
Kukulj, S.
Seiwerth, S. [2 ,3 ]
Misic, M. [3 ]
Redzepi, G. [1 ]
Samarzija, M. [2 ]
机构：
[1] Univ Hosp Ctr Zagreb, Dept Resp Dis Jordanovac, Zagreb, Croatia
[2] Univ Hosp Ctr Zagreb, Zagreb, Croatia
[3] Univ Hosp Ctr Zagreb, Clin Dept Pathol, Zagreb, Croatia
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
D O I：
10.1016/j.jtho.2017.09.1500
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.01-059
引用
收藏
页码：S2224 / S2224
页数：1
相关论文
共 50 条
  • [41] A Prospective Observational Study of Osimertinib Using Plasma Concentrations in NSCLC With Acquired EGFR T790M Mutation
    Nakagawa, T.
    Fukuhara, T.
    Imai, K.
    Igusa, R.
    Yokota, H.
    Watanabe, K.
    Suzuki, A.
    Morita, M.
    Inoue, A.
    Miura, M.
    Minamiya, Y.
    Maemondo, M.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S953 - S954
  • [42] Selection for the EGFR T790M gatekeeper resistance mutation may vary among different small molecule EGFR TKIs
    Chmielecki, Juliann
    Pietanza, Maria C.
    Kris, Mark
    Miller, Vincent
    Stout, Thomas
    Pao, William
    CANCER RESEARCH, 2010, 70
  • [43] Bronchoalveolar Lavage as an Alternative to Rebiopsy for Detection of T790M Mutation in NSCLC Patients with Acquired Resistance to EGFR-TKIs
    Kim, H.
    Hur, J. Y.
    Kim, I. A.
    Lee, S.
    Kim, W. S.
    Lee, K. Y.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S368 - S368
  • [44] Treatment of a NSCLC patient with osimertinib based on the detection of the EGFR T790M resistance mutation in cerebrospinal fluid
    Theoleyre, Sandrine
    Masson, Ingrid
    Herbreteau, Guillaume
    Vallee, Audrey
    Senellart, Helene
    Denis, Marc G.
    LUNG CANCER, 2017, 114 : 111 - 112
  • [45] Safety and Efficacy of Osimertinib in Treating an EGFR-Mutant Lung Cancer Patient with a Germline EGFR T790M Mutation
    Ma, W.
    Gong, J.
    Shan, J.
    Lewis, D.
    Xiao, W.
    Hung, J.
    Moore, E. H.
    Zhang, Y.
    Mans, N. Z.
    Welborn, J.
    Lam, K. S.
    Li, T.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1863 - S1864
  • [46] Osimertinib for EGFR T790M mutation-positive non-small cell lung cancer
    Soejima, Kenzo
    Yasuda, Hiroyuki
    Hirano, Toshiyuki
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (01) : 31 - 38
  • [47] The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M
    Huang, Yen-Hsiang
    Tseng, Jeng-Sen
    Hsu, Kuo-Hsuan
    Chen, Kun-Chieh
    Su, Kang-Yi
    Yu, Sung-Liang
    Chen, Jeremy J. W.
    Yang, Tsung-Ying
    Chang, Gee-Chen
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [48] Mechanisms of acquired resistance to osimertinib in advanced NSCLC with EGFR T790M mutation (LOGIK1607)
    Yamaguchi, Masafumi
    Osoegawa, Atsushi
    Nakamura, Tomomi
    Morinaga, Ryotaro
    Tanaka, Kentaro
    Kashiwabara, Kosuke
    Miura, Takashi
    Suetsugu, Takayuki
    Taguchi, Kenichi
    Nabeshima, Kazuki
    Kishimoto, Junji
    Sakai, Kazuko
    Nishio, Kazuto
    Sugio, Kenji
    CANCER SCIENCE, 2021, 112 : 567 - 567
  • [49] A Phase 2 Study of Befotertinib in Patients with EGFR T790M Mutated NSCLC after Prior EGFR TKIs
    Lu, S.
    Zhang, Y.
    Zhang, G.
    Zhou, J.
    Cang, S.
    Cheng, Y.
    Wu, G.
    Cao, P.
    Lv, D.
    Jian, H.
    Chen, C.
    Jin, X.
    Tian, P.
    Wang, K.
    Jiang, G.
    Chen, G.
    Chen, Q.
    Zhao, H.
    Ding, C.
    Guo, R.
    Sun, G.
    Wang, B.
    Jiang, L.
    Liu, Z.
    Fang, J.
    Yang, J.
    Zhuang, W.
    Liu, Y.
    Zhang, J.
    Pan, Y.
    Chen, J.
    Yu, Q.
    Zhao, M.
    Cui, J.
    Li, D.
    Yi, T.
    Yu, Z.
    Yang, Y.
    Zhang, Y.
    Zhi, X.
    Huang, Y.
    Wu, R.
    Chen, L.
    Zang, A.
    Cao, L.
    Li, Q.
    Li, X.
    Song, Y.
    Wang, D.
    Zhang, S.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S469 - S469
  • [50] Osimertinib in previously EGFR-TKI treated non-small cell lung cancer (NSCLC) patients without T790M mutation: Real-world evidence.
    Luo, Yung-Hung
    Liu, Han
    Wampfler, Jason A.
    Tazelaar, Henry D.
    Li, Yalun
    Peikert, Tobias
    Liu, Dan
    Leventakos, Konstantinos
    Chen, Yuh-Min
    Yang, Yanan
    Chiou, Shih-Hwa
    Yang, Ping
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345